日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).

间充质基质细胞(ORBCEL-M)疗法治疗糖尿病肾病的安全性和初步疗效:一项随机临床试验(NEPHSTROM)

Perico Norberto, Remuzzi Giuseppe, Griffin Matthew D, Cockwell Paul, Maxwell Alexander P, Casiraghi Federica, Rubis Nadia, Peracchi Tobia, Villa Alessandro, Todeschini Marta, Carrara Fabiola, Magee Bernadette A, Ruggenenti Piero L, Rota Stefano, Cappelletti Laura, McInerney Veronica, Griffin Tomás P, Islam Md Nahidul, Introna Martino, Pedrini Olga, Golay Josée, Finnerty Andrew A, Smythe Jon, Fibbe Willem E, Elliman Stephen J, O'Brien Timothy